{"abstract":"The Drug Enforcement Administration proposes placing butonitazene, flunitazene, and metodesnitazene including their isomers, esters, ethers, salts and salts of isomers, esters and ethers in schedule I of the Controlled Substances Act. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle these three specific controlled substances.","action":"Notice of proposed rulemaking.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2024/04/11/2024-07694.html","cfr_references":[{"chapter":null,"citation_url":null,"part":1308,"title":21}],"citation":"89 FR 25544","comment_url":null,"comments_close_on":"2024-05-13","correction_of":null,"corrections":[],"dates":"Comments must be submitted electronically or postmarked on or before May 13, 2024.","disposition_notes":null,"docket_ids":["Docket No. DEA-900N"],"dockets":[{"supporting_documents":[{"title":"Three Factor Analysis for Temporary Control of 7 benzimidazole-opioids","document_id":"DEA-2021-0031-0003"},{"title":"Three Factor Analysis for Temporary Control of 7 benzimidazole-opioids 11042021","document_id":"DEA-2021-0031-0002"}],"agency_name":"DEA","documents":[{"comment_count":2,"comment_start_date":"2024-04-11","updated_at":"2024-09-03T16:57:37.093-04:00","comment_url":"https://www.regulations.gov/commenton/DEA-2021-0031-0007","allow_late_comments":false,"id":"DEA-2021-0031-0007","comment_end_date":"2024-05-14","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":2,"id":"DEA-2021-0031","title":"Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I"}],"document_number":"2024-07694","effective_on":null,"end_page":25550,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2024/04/11/2024-07694.xml","html_url":"https://www.federalregister.gov/documents/2024/04/11/2024-07694/schedules-of-controlled-substances-placement-of-butonitazene-flunitazene-and-metodesnitazene","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2024-07694?publication_date=2024-04-11","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2024-04-11/2024-07694/mods.xml","not_received_for_publication":null,"page_length":7,"page_views":{"count":607,"last_updated":"2026-04-04 16:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-04-11/pdf/2024-07694.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-07694.pdf?1712753125","publication_date":"2024-04-11","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2024/04/11/2024-07694.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Three Factor Analysis for Temporary Control of 7 benzimidazole-opioids","document_id":"DEA-2021-0031-0003"},{"title":"Three Factor Analysis for Temporary Control of 7 benzimidazole-opioids 11042021","document_id":"DEA-2021-0031-0002"}],"comments_count":2,"agency_id":"DEA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=DEA-2021-0031","supporting_documents_count":2,"docket_id":"DEA-2021-0031","document_id":"DEA-2021-0031-0007","regulation_id_number":null,"title":"Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I","checked_regulationsdotgov_at":"2024-05-14T04:02:03Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":25544,"subtype":null,"title":"Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I","toc_doc":"Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I","toc_subject":"Schedules of Controlled Substances:\n","topics":["Administrative practice and procedure","Drug traffic control","Reporting and recordkeeping requirements"],"type":"Proposed Rule","volume":89}